BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 36556059)

  • 1.
    Ait Abdellah S; Scanzi J; Gal C; Martin M; Beck M; Ojetti V
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapist telephone-delivered CBT and web-based CBT compared with treatment as usual in refractory irritable bowel syndrome: the ACTIB three-arm RCT.
    Everitt H; Landau S; Little P; Bishop FL; O'Reilly G; Sibelli A; Holland R; Hughes S; Windgassen S; McCrone P; Goldsmith K; Coleman N; Logan R; Chalder T; Moss-Morris R
    Health Technol Assess; 2019 Apr; 23(17):1-154. PubMed ID: 31042143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome symptom severity improves equally with probiotic and placebo.
    Lyra A; Hillilä M; Huttunen T; Männikkö S; Taalikka M; Tennilä J; Tarpila A; Lahtinen S; Ouwehand AC; Veijola L
    World J Gastroenterol; 2016 Dec; 22(48):10631-10642. PubMed ID: 28082816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of
    Kim JY; Park YJ; Lee HJ; Park MY; Kwon O
    Food Sci Biotechnol; 2018 Jun; 27(3):853-857. PubMed ID: 30263811
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of administration of the Lactobacillus gasseri strain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome.
    Nobutani K; Sawada D; Fujiwara S; Kuwano Y; Nishida K; Nakayama J; Kutsumi H; Azuma T; Rokutan K
    J Appl Microbiol; 2017 Jan; 122(1):212-224. PubMed ID: 27761980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
    Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effectiveness of Synbiotic Preparation Containing
    Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety profile of LCR35 complete freeze-dried culture in irritable bowel syndrome: a randomized, double-blind study.
    Dapoigny M; Piche T; Ducrotte P; Lunaud B; Cardot JM; Bernalier-Donadille A
    World J Gastroenterol; 2012 May; 18(17):2067-75. PubMed ID: 22563194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical effectiveness of adding probiotics to a low FODMAP diet: Randomized double-blind placebo-controlled study.
    Turan B; Bengi G; Cehreli R; Akpınar H; Soytürk M
    World J Clin Cases; 2021 Sep; 9(25):7417-7432. PubMed ID: 34616808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
    Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
    Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bidirectional regulation of acupuncture: a subgroup analysis of multicenter randomized controlled trial of acupuncture with
    Guo J; Sun JH; Chen L; Geng H; Yang GH; Shen RR; Ding M; Lu J; Liu L; Fang XD; Pei LX
    Zhongguo Zhen Jiu; 2021 Aug; 41(8):845-50. PubMed ID: 34369692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of New
    Oh JH; Jang YS; Kang D; Chang DK; Min YW
    Nutrients; 2019 Nov; 11(12):. PubMed ID: 31783597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome With Predominant Abdominal Bloating: Short- and Long-term Results From a Placebo-Controlled Randomized Trial.
    Holvoet T; Joossens M; Vázquez-Castellanos JF; Christiaens E; Heyerick L; Boelens J; Verhasselt B; van Vlierberghe H; De Vos M; Raes J; De Looze D
    Gastroenterology; 2021 Jan; 160(1):145-157.e8. PubMed ID: 32681922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis.
    Didari T; Mozaffari S; Nikfar S; Abdollahi M
    World J Gastroenterol; 2015 Mar; 21(10):3072-84. PubMed ID: 25780308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.
    Cui S; Hu Y
    Int J Clin Exp Med; 2012; 5(3):238-44. PubMed ID: 22837798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double blind, placebo-controlled, randomized clinical trial that breast milk derived-
    Shin SP; Choi YM; Kim WH; Hong SP; Park JM; Kim J; Kwon O; Lee EH; Hahm KB
    J Clin Biochem Nutr; 2018 Mar; 62(2):179-186. PubMed ID: 29610559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of Lactobacillus strains as probiotics in the treatment of irritable bowel syndrome. Results from the LAPIBSS trial: Future objectives.
    Maixent JM; Pons O; Sennoune SR; Sadrin S
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):211-214. PubMed ID: 32538776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Tiropramide in the Treatment of Patients With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-blind, Non-inferiority Trial, Compared With Octylonium.
    Lee KN; Lee OY; Choi MG; Sohn CI; Huh KC; Park KS; Kwon JG; Kim N; Rhee PL; Myung SJ; Lee JS; Lee KJ; Park H; Lee YC; Choi SC; Jung HK; Jee SR; Choi CH; Kim GH; Park MI; Sung IK
    J Neurogastroenterol Motil; 2014 Jan; 20(1):113-21. PubMed ID: 24466452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.